Natural Products as Modulators of ABC Transporters in Breast Cancer
Phytotherapy Research · 2026-07 · 40 (7) · 4611-4637
DOI: 10.1002/ptr.70355 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, online erschienen am 13.05.2026. Verfasst von Yoganishalini Sagadevan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Sunway City, Malaysia. Hauptthemen laut MEDLINE: Biological Products, ATP-Binding Cassette Transporters, Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer remains a significant global health challenge, with high incidence and mortality rates despite advancements in early detection and treatment. Multidrug resistance (MDR), particularly in aggressive subtypes like triple‐negative breast cancer (TNBC), continues to hinder effective therapy. MDR is primarily driven by the overexpression of ATP‐binding cassette (ABC) transporters such as P‐gp, BCRP, and MRP1. ABC transporters actively efflux chemotherapeutic agents, reducing their efficacy and complicating treatment outcomes. This narrative review explores the potential of natural products to modulate ABC transporters as a strategy to mitigate MDR in breast cancer. A literature search was conducted across Ovid Medline, PubMed, Scopus, Embase, Web of Science, and EBSCOhost. Articles underwent a two‐stage screening process (title and abstract and full text), with additional manual searches of reference lists. The results show that natural products derived from plants can inhibit ABC transporters through suppression of protein expression, downregulation of mRNA expression, and inhibition of drug efflux functions. Additionally, they target indirect regulatory pathways, such as NF‐κB, YB‐1, PI3K/Akt, and ATPase activity, further contributing to the reversal of MDR. These compounds work synergistically with chemotherapeutic agents like doxorubicin and paclitaxel to enhance drug retention and efficacy while reducing toxicity. This multifaceted approach highlights the potential of natural products as valuable adjunct therapies in breast cancer treatment, offering new strategies to overcome drug resistance and improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Sunway City, Malaysia.
- Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
ORCID-Profile: Yoganishalini Sagadevan, Reyhaneh Farghadani, Ammu K Radhakrishnan
Zitieren
APA
Sagadevan, Y., Farghadani, R., & Radhakrishnan, A. K. (2026). Natural Products as Modulators of ABC Transporters in Breast Cancer. Phytotherapy Research, 40(7), 4611-4637. https://doi.org/10.1002/ptr.70355
Vancouver
Sagadevan Y, Farghadani R, Radhakrishnan AK. Natural Products as Modulators of ABC Transporters in Breast Cancer. Phytotherapy Research. 2026;40(7):4611-4637. doi:10.1002/ptr.70355
BibTeX
@article{Sagadevan2026,
author = {Sagadevan, Yoganishalini and Farghadani, Reyhaneh and Radhakrishnan, Ammu K},
title = {Natural Products as Modulators of ABC Transporters in Breast Cancer},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {7},
pages = {4611--4637},
doi = {10.1002/ptr.70355}
}
EUVIMED